stars 1 stars 2 stars 3

Noventure is a portfolio of clinically proven, consumer-facing healthcare brands trusted by healthcare professionals and patients in more than 50 countries. Our mission is to build trust for people all around the world by providing clinically-backed products that offer real relief without harm—so they can live healthier, freer lives without fear or doubt in their care. Our brands, including Tasectan, Utipro Plus, and Ulkox, are: • Backed by clinical trials • Included in treatment guidelines • CE-marked and MDR Class III compliant • Protected by patents We work with leading pharmaceutical partners worldwide to make our products the number one choice in their therapeutic class.

Noventure Questions

The Noventure annual revenue was $9 million in 2026.

Ignacio Mena is the Managing Director of Noventure.

17 people are employed at Noventure.

Noventure is based in Barcelona, Catalonia.

The NAICS codes for Noventure are [424, 42421, 42, 4242].

The SIC codes for Noventure are [51, 512].

Top Noventure Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users